Upgrade to SI Premium - Free Trial

GeneDx (WGS) PT Lowered to $55 at TD Cowen

May 5, 2026 8:53 AM
TD Cowen analyst Dan Brennan lowered the price target on GeneDx (NASDAQ: WGS) to $55.00 (from $90.00) while maintaining a Buy rating.

Categories

Analyst PT Change